PATENT CLAIM ANALYSIS

Application Number: 15860483
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "267000"]

Abstract:
Compounds useful as kinase inhibitors are provided herein, as well as salts, pharmaceutical compositions, methods of medical treatment and methods of synthesis thereof.

Claim (Index 8):
The compound of  claim 6 , wherein two R 31 s on the same ring atom together with the ring atom to which they are attached form a 3-8 membered cycle.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15348862', '14982443', '14498796', '15348770', '15288878']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7519809762648231
- 35 USC 102 Novelty (BERT): 0.5239235451199102
- Combined Prediction Score: 0.7291752331503317
- Mean Citation Score: 297.033728
- Max Citation Score: 315.8864700000001
- Similarity Product: 254.44170352347496

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test